Skip to main content

Read the latest news about research and scientific resultats on Alzheimer's disease at the Barcelonaβeta Brain Research Center (BBRC).

16 Sep | 2020

The FDA accepts license application for aducanumab, the first possible disease modifying drug for Alzheimer’s

Dr José Luis Molinuevo comments the possible approval of Biogen’s new treatment, in an interview for the podcast Saving Minds.

04 Sep | 2020

Marc Suárez-Calvet is awarded an ERC Starting Grant to identify age-related blood factors as a therapeutic target for Alzheimer’s disease

The research, endowed with nearly 1.5 milion euros, will provide a new therapeutic target for Alzheimer's disease, in which age is the most important risk factor

03 Aug | 2020

Proximity to parental age at onset of Alzheimer's indicates an increased risk of developing the disease in women

The study also points out that, with age, people who have experienced episodes of anxiety or depression in the past have increased hippocampal atrophy

25 May | 2020

Air pollution causes damage to brain areas linked to Alzheimer's

BBRC researchers have detected that people most exposed to air pollution have greater brain atrophy and less cortical thickness in specific areas of the brain that are affected in Alzheimer's disease.

24 Apr | 2020

BBRC researchers working abroad tell us how they are living the COVID-19 pandemic

Four researchers explain in a video (in Spanish) how they are working with this new scenario

28 Jan | 2020

“The Marie Skłodowska-Curie grant allowed me to come back to Barcelona and to clinical research”

Dr Marc Suárez-Calvet explains his experience and the current stage of the project that he has led with European funding

07 Jan | 2020

New study finds changes in brain structure and cognition in people with insomnia

The research opens the door to a new line of research that will analyze the relationship between sleep quality and Alzheimer’s risk

04 Dec | 2019

New study relates alterations in white and gray matters and cognition

The results complement previous findings with participants of the Alfa Study